NasdaqCM - Nasdaq Real Time Price USD

Adial Pharmaceuticals, Inc. (ADIL)

1.4200 -0.0200 (-1.39%)
At close: 4:00 PM EDT
1.3500 -0.07 (-4.93%)
After hours: 4:57 PM EDT

Earnings Estimate

CURRENCY IN USD Current Qtr. (Mar 2024)Next Qtr. (Jun 2024)Current Year (2024)Next Year (2025)
No. of Analysts 1122
Avg. Estimate -0.33-0.33-1.99-1.59
Low Estimate -0.33-0.33-2.62-1.92
High Estimate -0.33-0.33-1.36-1.27
Year Ago EPS -2.750.96-3.6-1.99

Revenue Estimate

CURRENCY IN USD Current Qtr. (Mar 2024)Next Qtr. (Jun 2024)Current Year (2024)Next Year (2025)
No. of Analysts 1111
Avg. Estimate --------
Low Estimate --------
High Estimate --------
Year Ago Sales --------
Sales Growth (year/est) --------

Earnings History

CURRENCY IN USD 3/31/2023 6/30/2023 9/30/2023 12/31/2023
EPS Est. -3.5-1.5-1.13-0.76
EPS Actual -2.750.96-1.18-1.35
Difference 0.752.46-0.05-0.59
Surprise % 21.40%164.00%-4.40%-77.60%

EPS Trend

CURRENCY IN USD Current Qtr. (Mar 2024)Next Qtr. (Jun 2024)Current Year (2024)Next Year (2025)
Current Estimate -0.33-0.33-1.99-1.59
7 Days Ago -0.33-0.33-1.99-1.59
30 Days Ago -0.33-0.33-1.99-1.59
60 Days Ago -0.37-0.37-1.46-12.82
90 Days Ago -0.37-0.37-3.45-7.91

EPS Revisions

CURRENCY IN USD Current Qtr. (Mar 2024)Next Qtr. (Jun 2024)Current Year (2024)Next Year (2025)
Up Last 7 Days --------
Up Last 30 Days --------
Down Last 7 Days --------
Down Last 30 Days --------

Growth Estimates

CURRENCY IN USD ADILIndustrySectorS&P 500
Current Qtr. 88.00%----8.30%
Next Qtr. -134.40%----12.40%
Current Year 44.70%----5.60%
Next Year 20.10%----13.10%
Next 5 Years (per annum) ------11.13%
Past 5 Years (per annum) --------

Research Analysis

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Earnings

Consensus EPS
 

Related Tickers